Nanjing Well Pharmaceutical Group Co.,Ltd. Stock
Equities
603351
CNE100003JD4
Oil & Gas Refining and Marketing
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
20.69 CNY | +1.62% |
|
-11.20% | -21.54% |
Sales 2022 | 1.11B 153M | Sales 2023 | 1.16B 159M | Capitalization | 3.57B 493M |
---|---|---|---|---|---|
Net income 2022 | 95M 13.11M | Net income 2023 | 112M 15.45M | EV / Sales 2022 | 2.93 x |
Net Debt 2022 | 325M 44.86M | Net Debt 2023 | 328M 45.28M | EV / Sales 2023 | 3.37 x |
P/E ratio 2022 |
30.5
x | P/E ratio 2023 |
31.8
x | Employees | 673 |
Yield 2022 |
1.29% | Yield 2023 |
1.14% | Free-Float | 37.11% |
1 day | +1.62% | ||
1 week | -11.20% | ||
Current month | -11.20% | ||
1 month | -19.53% | ||
3 months | -1.43% | ||
6 months | -21.36% | ||
Current year | -21.54% |
![Extreme 20.12](/images/extremecours_fleche.png)
![Extreme 20.12](/images/extremecours_fleche.png)
![Extreme 17.65](/images/extremecours_fleche.png)
![Extreme 17.65](/images/extremecours_fleche.png)
![Extreme 17.08](/images/extremecours_fleche.png)
![Extreme 17.08](/images/extremecours_fleche.png)
![Extreme 17.08](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Ren Rong Wu
CEO | Chief Executive Officer | 61 | 00-01-31 |
Qun Song Tang
DFI | Director of Finance/CFO | 56 | 00-01-31 |
Rong Wen Wu
CHM | Chairman | 58 | 00-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ya Mei Guan
BRD | Director/Board Member | 54 | 23-05-17 |
Ren Rong Wu
CEO | Chief Executive Officer | 61 | 00-01-31 |
Zheng Song Gao
CTO | Chief Tech/Sci/R&D Officer | 58 | 00-01-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 20.69 | +1.62% | 805,900 |
24-06-06 | 20.36 | -4.23% | 1,071,880 |
24-06-05 | 21.26 | -0.98% | 773,200 |
24-06-04 | 21.47 | -6.73% | 2,048,702 |
End-of-day quote Shanghai S.E., June 06, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-21.54% | 387M | |
+13.84% | 238B | |
+19.56% | 99.74B | |
+17.51% | 61.69B | |
+3.74% | 58.54B | |
+18.92% | 50.5B | |
+19.89% | 34.63B | |
+27.23% | 27.08B | |
-18.46% | 19.32B | |
+9.29% | 19.2B |
- Stock Market
- Equities
- 603351 Stock